LifeMD, Inc.
LFMD
$6.09
$0.030.50%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 64.25M | 53.39M | 50.66M | 44.14M | 44.86M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 64.25M | 53.39M | 50.66M | 44.14M | 44.86M |
Cost of Revenue | 9.43M | 5.01M | 5.02M | 4.60M | 5.36M |
Gross Profit | 54.82M | 48.38M | 45.64M | 39.54M | 39.50M |
SG&A Expenses | 49.05M | 48.63M | 47.87M | 41.55M | 38.24M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | 2.35M | 1.82M | 1.67M | 2.07M | 1.44M |
Total Operating Expenses | 63.24M | 58.08M | 56.97M | 50.32M | 47.03M |
Operating Income | 1.02M | -4.69M | -6.31M | -6.17M | -2.17M |
Income Before Tax | 404.20K | -5.24M | -6.84M | -6.65M | -2.79M |
Income Tax Expenses | 169.50K | 232.50K | -- | -- | 428.00K |
Earnings from Continuing Operations | 234.70K | -5.48M | -6.84M | -6.65M | -3.22M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -341.00K | 345.80K | -38.60K | -119.40K | -509.90K |
Net Income | -106.30K | -5.13M | -6.88M | -6.77M | -3.73M |
EBIT | 1.02M | -4.69M | -6.31M | -6.17M | -2.17M |
EBITDA | 1.43M | -4.29M | -5.96M | -5.86M | -1.87M |
EPS Basic | -0.02 | -0.14 | -0.19 | -0.19 | -0.12 |
Normalized Basic EPS | 0.00 | -0.07 | -0.10 | -0.11 | -0.06 |
EPS Diluted | -0.02 | -0.14 | -0.19 | -0.19 | -0.13 |
Normalized Diluted EPS | 0.00 | -0.07 | -0.10 | -0.11 | -0.06 |
Average Basic Shares Outstanding | 42.21M | 42.02M | 41.30M | 39.24M | 36.74M |
Average Diluted Shares Outstanding | 42.21M | 42.02M | 41.30M | 39.24M | 36.74M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -730.73% | -15.13% | -11.29% | -11.47% | -20.81% |